Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Total 13F shares
-
52,958,336
-
Share change
-
+1,355,665
-
Total reported value
-
$9,771,240,814
-
Put/Call ratio
-
196%
-
Price per share
-
$184.60
-
Number of holders
-
625
-
Value change
-
+$238,492,914
-
Number of buys
-
241
-
Number of sells
-
355
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q4 2024
As of 31 Dec 2024,
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) was held by
625 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,958,336 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Allspring Global Investments Holdings, LLC, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Impactive Capital LP, Meritage Group LP, and ARIEL INVESTMENTS, LLC.
This page lists
630
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.